Two Sigma Advisers’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Two Sigma Advisers’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,110	Closed	-$7.83K	–	2793
2022 Q4	$7.83K	Buy	2,110 +160	+8%	+$707	﹤0.01%	2464
2022 Q3	$10K	Buy	+1,950	New	+$10.9K	﹤0.01%	2484
2022 Q2	–	Sell	-1,590	Closed	-$11K	–	2946
2022 Q1	$11K	Sell	1,590 -17,380	-92%	-$170K	﹤0.01%	2695
2021 Q4	$250K	Buy	+18,970	New	+$314K	﹤0.01%	2203
2021 Q1	–	Sell	-1,590	Closed	-$69K	–	2766
2020 Q4	$69K	Buy	+1,590	New	+$71.2K	﹤0.01%	2299
2020 Q3	–	Sell	-1,150	Closed	-$69K	–	2686
2020 Q2	$69K	Sell	1,150 -1,150	-50%	-$105K	﹤0.01%	2405
2020 Q1	$173K	Buy	+2,300	New	+$265K	﹤0.01%	2209

Other funds holding ORTX

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Kapitalo Investimentos Sao Paulo, Brazil $531M AUM 25.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Two Sigma Advisers's ORTX Position: Q1 2023 in Review

Two Sigma Advisers sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2023, closing a stake of 2,110 shares — an estimated $7.83K sold.

Two Sigma Advisers first reported a position in ORTX in Q1 2020 and held it in 7 quarters. The position peaked at $250K in Q4 2021. 35 funds tracked by Wall St. Rank hold ORTX as of Q1 2023.

Two Sigma Advisers reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2023 after selling out during the quarter.
Two Sigma Advisers sold 2,110 Orchard Therapeutics plc American Depositary Shares shares in Q1 2023, an estimated $7.83K.
Two Sigma Advisers first reported a position in Orchard Therapeutics plc American Depositary Shares in Q1 2020 and held it in 7 quarters.
Two Sigma Advisers's Orchard Therapeutics plc American Depositary Shares position peaked at $250K in Q4 2021.
35 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2023.

Based on Two Sigma Advisers's 13F filing for Q1 2023, filed 15 May 2023.